Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay (Q43036577)

12 November 2017

title

Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay (English)

1 reference

12 November 2017

1 reference

1 reference

Ross RS

1

1 reference

12 November 2017

Viazov S

2

1 reference

12 November 2017

Sarr S

3

1 reference

12 November 2017

Hoffmann S

4

1 reference

12 November 2017

Kramer A

5

1 reference

12 November 2017

Roggendorf M

6

1 reference

12 November 2017

publication date

1 March 2002

1 reference

Journal of Virological Methods

12 November 2017

published in

1 reference

12 November 2017

volume

101

1 reference

12 November 2017

issue

1-2

1 reference

12 November 2017

page(s)

159-168

1 reference

Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

The scientific challenge of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Standardization of hepatitis C virus--RNA quantification: advances and unfinished business

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Hepatitis C in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Comparison of quantitative HCV RNA assays in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Standardized hepatitis C virus RNA panels for nucleic acid testing assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Hepatitis C viral dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Standardization of hepatitis C virus RNA quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Performance of an automated system for quantification of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Risk of hepatitis C transmission from infected medical staff to patients: model-based calculations for surgical settings

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Typing of hepatitis C virus isolates by DNA enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Clinical implications of hepatitis C viral kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900433-5

7 January 2021

10.1016/S0166-0934(01)00433-5

Identifiers

DOI

1 reference

12 November 2017

1 reference